This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
stock-price-change: Archive
DNOW (DNOW) Crossed Above the 200-Day Moving Average: What That Means for Investors
by Zacks Equity Research
Is it a good or bad thing when a stock surpasses resistance at the 200-day simple moving average?
DNOWNegative Net Change
momentum-stocks price-change stock-price-change stock-price-movement stocks-moving-today
Here's Why Momentum in Soleno Therapeutics (SLNO) Should Keep going
by Zacks Equity Research
Soleno Therapeutics (SLNO) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.
SLNOPositive Net Change
price-performance stock-price-change stock-price-movement
Tutor Perini (TPC) is on the Move, Here's Why the Trend Could be Sustainable
by Zacks Equity Research
Tutor Perini (TPC) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our shorter-term trading strategy-based screen.
TPCPositive Net Change
price-performance stock-price-change stock-price-movement
Recent Price Trend in The Japan Steel Works (JPSWY) is Your Friend, Here's Why
by Zacks Equity Research
If you are looking for stocks that are well positioned to maintain their recent uptrend, The Japan Steel Works (JPSWY) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.
JPSWYNo Net Change
price-performance stock-price-change stock-price-movement
Mirion Technologies (MIR) is on the Move, Here's Why the Trend Could be Sustainable
by Zacks Equity Research
Mirion Technologies (MIR) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.
MIRPositive Net Change
price-performance stock-price-change stock-price-movement
Recent Price Trend in SPX Technologies (SPXC) is Your Friend, Here's Why
by Zacks Equity Research
SPX Technologies (SPXC) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.
SPXCPositive Net Change
price-performance stock-price-change stock-price-movement
Here's Why Momentum in Grand Canyon Education (LOPE) Should Keep going
by Zacks Equity Research
Grand Canyon Education (LOPE) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "Recent Price Strength" screen.
LOPENegative Net Change
price-performance stock-price-change stock-price-movement
Recent Price Trend in Carriage Services (CSV) is Your Friend, Here's Why
by Zacks Equity Research
If you are looking for stocks that are well positioned to maintain their recent uptrend, Carriage Services (CSV) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.
CSVNegative Net Change
price-performance stock-price-change stock-price-movement
Sterling Infrastructure (STRL) is on the Move, Here's Why the Trend Could be Sustainable
by Zacks Equity Research
If you are looking for stocks that are well positioned to maintain their recent uptrend, Sterling Infrastructure (STRL) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.
STRLNegative Net Change
price-performance stock-price-change stock-price-movement
Analysts Estimate Flowers Foods (FLO) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Flowers Foods (FLO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
FLOPositive Net Change
consensus-outlook earnings earnings-consensus earnings-esp earnings-estimates-revisions earnings-expectations earnings-preview stock-price-change zacks-consensus-estimate
BitFuFu Inc. (FUFU) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
BitFuFu Inc. (FUFU) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
FUFUNegative Net Change CANPositive Net Change
consensus-outlook earnings earnings-consensus earnings-esp earnings-estimates-revisions earnings-expectations earnings-preview stock-price-change zacks-consensus-estimate
Here's Why Foghorn Therapeutics (FHTX) Looks Ripe for Bottom Fishing
by Zacks Equity Research
Foghorn Therapeutics (FHTX) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term.
FHTXPositive Net Change
momentum-investor momentum-stocks stock-price-change stock-price-movement
What Makes Idaho Strategic Resources (IDR) a Good Fit for 'Trend Investing'
by Zacks Equity Research
Idaho Strategic Resources (IDR) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "Recent Price Strength" screen.
IDRNegative Net Change
price-performance stock-price-change stock-price-movement
Recent Price Trend in Century (CENX) is Your Friend, Here's Why
by Zacks Equity Research
Century (CENX) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "Recent Price Strength" screen.
CENXPositive Net Change
price-performance stock-price-change stock-price-movement
Barrett (BBSI) is on the Move, Here's Why the Trend Could be Sustainable
by Zacks Equity Research
Barrett (BBSI) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our shorter-term trading strategy-based screen.
BBSINegative Net Change
price-performance stock-price-change stock-price-movement
What Makes Zevra Therapeutics (ZVRA) a Good Fit for 'Trend Investing'
by Zacks Equity Research
Zevra Therapeutics (ZVRA) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "Recent Price Strength" screen.
ZVRAPositive Net Change
price-performance stock-price-change stock-price-movement
Will Ontrak, Inc. (OTRK) Report Negative Q2 Earnings? What You Should Know
by Zacks Equity Research
Ontrak (OTRK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
consensus-outlook earnings earnings-consensus earnings-esp earnings-estimates-revisions earnings-expectations earnings-preview stock-price-change zacks-consensus-estimate
SAB Biotherapeutics, Inc. (SABS) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release
by Zacks Equity Research
SAB Biotherapeutics (SABS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
SABSPositive Net Change ABSIPositive Net Change
consensus-outlook earnings earnings-consensus earnings-esp earnings-estimates-revisions earnings-expectations earnings-preview stock-price-change zacks-consensus-estimate
Atlanticus Holdings Corporation (ATLC) Earnings Expected to Grow: What to Know Ahead of Q2 Release
by Zacks Equity Research
Atlanticus (ATLC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
ATLCNegative Net Change MRXNegative Net Change
consensus-outlook earnings earnings-consensus earnings-esp earnings-estimates-revisions earnings-expectations earnings-preview stock-price-change zacks-consensus-estimate
Birkenstock (BIRK) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Birkenstock (BIRK) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
BIRKNegative Net Change
consensus-outlook earnings earnings-consensus earnings-esp earnings-estimates-revisions earnings-expectations earnings-preview stock-price-change zacks-consensus-estimate
Earnings Preview: Dianthus Therapeutics, Inc. (DNTH) Q2 Earnings Expected to Decline
by Zacks Equity Research
Dianthus Therapeutics, Inc. (DNTH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
DNTHPositive Net Change INOPositive Net Change
consensus-outlook earnings earnings-consensus earnings-esp earnings-estimates-revisions earnings-expectations earnings-preview stock-price-change zacks-consensus-estimate
Globant (GLOB) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Globant (GLOB) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
GLOBPositive Net Change
consensus-outlook earnings earnings-consensus earnings-esp earnings-estimates-revisions earnings-expectations earnings-preview stock-price-change zacks-consensus-estimate
Life360 (LIF) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
by Zacks Equity Research
Life360 (LIF) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
LIFPositive Net Change SSTIPositive Net Change
consensus-outlook earnings earnings-consensus earnings-esp earnings-estimates-revisions earnings-expectations earnings-preview stock-price-change zacks-consensus-estimate
Piedmont Lithium Inc. - Sponsored ADR (PLL) Expected to Beat Earnings Estimates: Should You Buy?
by Zacks Equity Research
Piedmont Lithium Inc. - Sponsored ADR (PLL) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
consensus-outlook earnings earnings-consensus earnings-esp earnings-estimates-revisions earnings-expectations earnings-preview stock-price-change zacks-consensus-estimate
Tapestry (TPR) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Tapestry (TPR) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
TPRNegative Net Change XELBNo Net Change
consensus-outlook earnings earnings-consensus earnings-esp earnings-estimates-revisions earnings-expectations earnings-preview stock-price-change zacks-consensus-estimate